Methods and Processes of Developing the Strengthening the Reporting of Observational Studies in Epidemiology - Veterinary (STROBE-Vet) Statement. by Sargeant, J M et al.
In order to encourage dissemination of the STROBE-Vet Statement, this article is published in the fol-
lowing journals: Journal of Food Protection, Journal of Swine Health and Production, Journal of Veter-
inary Internal Medicine, Preventive Veterinary Medicine, Zoonoses and Public Health. The Explanation
and Elaboration STROVE-Vet documents for each checklist item is available in companion publications
in Journal of Veterinary Internal Medicine and, Zoonoses and Public Health. The original STROBE
statement is published in Journal of Clinical Epidemiology website (http://www.jclinepi.com), Annals of
Internal Medicine, BMJ, Bulletin of the World Health Organization, Epidemiology, The Lancet, PLoS
Medicine, and Preventive Medicine. The authors jointly own the copyright of this article.
Methods and Processes of Developing the Strengthening the
Reporting of Observational Studies in Epidemiology – Veterinary
(STROBE-Vet) Statement
J.M. Sargeant, A.M. O’Connor, I.R. Dohoo, H.N. Erb, M. Cevallos, M. Egger, A.K. Ersbøll, S.W. Martin,
L.R. Nielsen, D.L. Pearl, D.U. Pfeiﬀer, J. Sanchez, M.E. Torrence, H. Vigre, C. Waldner, and M.P. Ward
Background: Reporting of observational studies in veterinary research presents challenges that often are not addressed in
published reporting guidelines.
Objective: To develop an extension of the STROBE (Strengthening the Reporting of Observational Studies in Epidemiol-
ogy) statement that addresses unique reporting requirements for observational studies in veterinary medicine related to
health, production, welfare, and food safety.
Design: Consensus meeting of experts.
Setting: Mississauga, Canada.
Participants: Seventeen experts from North America, Europe, and Australia.
Methods: Experts completed a pre-meeting survey about whether items in the STROBE statement should be modiﬁed or
added to address unique issues related to observational studies in animal species with health, production, welfare, or food
safety outcomes. During the meeting, each STROBE item was discussed to determine whether or not rewording was recom-
mended and whether additions were warranted. Anonymous voting was used to determine consensus.
Results: Six items required no modiﬁcations or additions. Modiﬁcations or additions were made to the STROBE items 1
(title and abstract), 3 (objectives), 5 (setting), 6 (participants), 7 (variables), 8 (data sources/measurement), 9 (bias), 10 (study
size), 12 (statistical methods), 13 (participants), 14 (descriptive data), 15 (outcome data), 16 (main results), 17 (other analy-
ses), 19 (limitations), and 22 (funding).
Conclusion: The methods and processes used were similar to those used for other extensions of the STROBE statement.
The use of this STROBE statement extension should improve reporting of observational studies in veterinary research by rec-
ognizing unique features of observational studies involving food-producing and companion animals, products of animal ori-
gin, aquaculture, and wildlife.
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Observational studies are a common methodologi-cal approach in veterinary research and have
been used to estimate the frequency of a disease or
condition, test hypotheses, generate new hypotheses,
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or generate data suitable as input for systematic
reviews and meta-analyses, risk assessments, and other
data-dependent models, such as mathematical and
simulated disease models. Thus, observational studies
may be used to estimate the prevalence or incidence
of a condition, to investigate the distribution of con-
ditions in time and space, to explore risk factors and
compare management options, to create explanatory
models, or to evaluate diagnostic test accuracy. Com-
prehensive and transparent reporting of an observa-
tional study’s design, execution, and results is
essential for the interpretation of the research in
terms of evaluating its applicability for the reader and
its potential for bias and for the data to be used as
input for other studies, such as meta-analyses and
risk assessments. The peer-review process also beneﬁts
from guidelines describing appropriate reporting. In
human healthcare, inadequacies in reporting of key
information in observational studies have been docu-
mented.1–3 Although there is less documented empiri-
cal evidence of deﬁciencies in reporting observational
studies in veterinary medicine, absence of evidence is
not evidence of absence. Indeed, some evidence of
inadequate reporting exists in the literature on pre-
harvest food safety.4
The STROBE statement (www.strobe-statement.org)
was developed to provide guidance for the reporting of
observational studies related to human health. It con-
sists of a 22-item checklist that is accompanied by a
document describing the development of the STROBE
statement5 and an elaboration document that provides
explanations of each item, as well as examples of com-
plete reporting of each item.6 The STROBE guidelines
focus on cohort, case-control, and cross-sectional stud-
ies of aspects of human medicine and public health,
although many of the principles also apply to other
observational study designs, such as hybrid designs or
ecologic studies. The STROBE statement has been
modiﬁed for use in speciﬁc content areas within epi-
demiology, including genetic association studies
(STREGA),7 molecular epidemiology (STROBE-ME),8
and molecular epidemiology for infectious diseases
(STROME-ID).9
There are some nuances of conducting and reporting
studies in animal populations that are unique from
other areas of epidemiology.10 Thus, the CONsolidated
Standards of Reporting Trials (CONSORT) statement
for reporting randomized controlled trials in human
medicine11 was previously modiﬁed for use in veterinary
medicine. The result was the creation and publication
of the reporting guidelines for randomized controlled
trials for livestock and food safety (REFLECT) state-
ment.12,13 Similarly, while the STROBE statement and
the accompanying elaboration document provide an
excellent resource for conducting, reporting, and read-
ing observational studies, modiﬁcations to address
speciﬁc issues in veterinary medicine will increase its
applicability in this ﬁeld.10
Here, we describe the methods and processes used to
develop an extension of the STROBE statement that
forms the basis for the standardized reporting guidelines
for observational studies in veterinary medicine
(STROBE-Vet). As a separate companion paper, the
STROBE-Vet explanation and elaboration document14
provides the methodological background for the items
contained in the STROBE-Vet statement, as well as illus-
trative examples of appropriate reporting. We strongly
recommend that the STROBE-Vet checklist be used in
conjunction with the explanation and elaboration docu-
ment for all observational studies related to animal
health, production, welfare, or food safety outcomes.
Methods
The process for extending reporting guideline statements (e.g,
STROBE and CONSORT) to meet the speciﬁc needs of individual
disciplines has been documented.15,16 We used these reports to
design the approach used for developing the statement reported
herein.
Steering Committee
A steering committee was responsible for the development of
the revised veterinary extension of the STROBE statement. This
group, comprised of four members (co-authors JMS, AMOC,
HNE, and IRD), ﬁrst met to discuss the idea in December 2012.
The committee agreed to explore the need for modifying the origi-
nal STROBE statement and to use the approach reported previ-
ously as a guideline for the modiﬁcation.16 The committee secured
funding for the project, identiﬁed potential participants, invited
the potential participants to attend a consensus meeting, organized
the meeting, and was responsible for subsequent steps involved in
preparation and publication of the papers as detailed below.
Funding
Funding was required to cover the costs of the consensus meet-
ing (e.g, travel, accommodations, and meeting rooms). The deci-
sion was made by the steering committee not to seek funding from
pharmaceutical or biologic companies commonly associated with
veterinary research. Eﬀorts to obtain funding were limited to not-
for-proﬁt non-government organizations, academic institutions,
and a publishing company. Funding was received from the Cana-
dian Association for Veterinary Epidemiology and Preventive
Medicine (CAVEPM), the Centre for Veterinary Epidemiology
(CVER) at the University of Prince Edward Island, the Centre for
Public Health and Zoonoses (CPHAZ) at the University of
Guelph, Iowa State University, Cornell University, and the pub-
lishing company VER Inc, Prince Edward Island, Canada. Suﬃ-
cient funds were obtained to pay for all local expenses for the
participants at the consensus meeting. Funds to cover travel costs
for participants were not obtained; therefore, in general, partici-
pants fully funded their own travel and the sources of these funds
were not identiﬁed.
Identification of Participants
The committee’s aim was to bring together a group of experts
familiar with the design, conduct, and statistical analysis of obser-
vational studies concerning animal health, production, welfare,
and food safety. Another aim was to include researchers with
experience in a wide variety of areas, including food animal pro-
duction, companion animal medicine, veterinary public health, and
food safety. Representation from multiple countries was sought,
with an eﬀort to include several participants with relevant editorial
experience.
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The steering committee decided to limit the size of the meeting
to approximately 20 participants, including the four committee
members. The size limitation was based on funding and the need
for a group size that facilitated interaction and active discussion.
The steering committee identiﬁed experts for invitation based on
areas of expertise (many with multiple areas) and geographic loca-
tions. Invitations to attend the meeting were sent via email by
JMS to the ﬁrst 20 individuals on the list. The email invitation
requested that individuals wishing to participate commit to:
(1) completing a pre-meeting survey to determine whether modiﬁ-
cations to the checklist items of the STROBE statement seemed
necessary for veterinary medicine, and if so, to suggest appropriate
modiﬁcations; (2) attending a consensus meeting in Mississauga,
Canada; and (3) self-funding their travel to that meeting. If an ini-
tial invitation was declined, an alternative individual with similar
expertise and from the same geographic region was contacted by
means of the same email invitation.
The steering committee also contacted the authors of the original
STROBE statement papers to inform them of our interest in modify-
ing the STROBE statement and to solicit support for, and participa-
tion in, the initiative.
Identification of Specific Issues
By the approach described previously,16 a survey was sent to the
invitees soliciting input on each checklist item in the STROBE state-
ment to improve relevance to observational studies related to animal
health, production, welfare, and food safety. The intent of this sur-
vey was to guide discussion at the consensus meeting; thus, human
ethics approval was not required. The survey was sent by email as a
spreadsheet attachment to the invitees, as well as to individuals who
were invited, but were unable to attend the meeting and had indi-
cated that they still wished to provide input by completing the sur-
vey. The survey included the 22 items of the STROBE statement
and asked the respondents to indicate whether each item should be
modiﬁed (yes/no) and, if yes, to describe the modiﬁcations that the
respondent felt would be appropriate. At the end of each section
(Abstract, Introduction, Methods, Results, Discussion, and Conclu-
sion), space was provided for the respondents to propose additional
items of relevance for reporting on studies related to animal health,
production, welfare, or food safety.
After the surveys were returned, the responses for each checklist
item were anonymously compiled.
The Consensus Meeting
A 2 1/2-day consensus meeting was held on May 11-13, 2014 in
Mississauga, Ontario, Canada, with a total of 17 participants from
Australia, Canada, Denmark, the United Kingdom, and the Uni-
ted States of America, as well as two assistants for logistical sup-
port and documentation. Before the meeting, participants were
provided with an electronic copy of the STROBE statement5 and
its elaboration document,6 as well as the results of the survey. At
the meeting, participants were provided with the same materials in
printed form.
The meeting began with an evening session consisting of intro-
ductions, an overview presentation on reporting guidelines in gen-
eral and their relevance to veterinary medicine, and a discussion of
the format for the meeting, the scope of the initiative, and the
expectations of the participants in the guideline-development pro-
cess. This included a discussion and vote on the approach that
would be used to reach consensus. To facilitate conﬁdential voting
and recording of the voting results throughout the meeting, elec-
tronic remote voting devices were used. Three voting criteria were
discussed as indicators of consensus: unanimous agreement among
the 17 experts minus 2 (88%), minus 3 (82%), or minus 5 (70%).
The participants agreed that a unanimous vote minus three per-
sons would be required for consensus. In same instances, experts
would leave the room for brief periods. In this case, at least 16
experts had to participate in each vote, with unanimous vote
minus three still deﬁning consensus.
At the start of the ﬁrst full day of discussion, two of the
authors (Myriam Cevallos and Matthias Egger) of the STROBE
statement papers attended by teleconference. They provided an
overview of the process for developing the STROBE statement,
common uses and misuses, and a discussion of STROBE statement
extensions.
For the remainder of the meeting, the following approach was
used for the STROBE statement checklist items 1 through 22. Ini-
tially, the moderator described the item, the key elements of that
item as presented in the STROBE elaboration document, and the
suggestions from the pre-meeting survey for modifying that item.
The discussion sessions were moderated alternately by one of two
members of the steering committee (JMS and AMOC). The mod-
erator facilitated a group discussion of the key elements, including
a discussion as to whether the proposed modiﬁcations should
result in modiﬁcation of the wording of the STROBE item. Fol-
lowing the discussion, participants (including both moderators)
voted to accept or reject the modiﬁcations to the wording of the
statement item. If there were no modiﬁcations proposed, the vote
was to accept the item as originally written. If an item received
suﬃcient votes to indicate consensus, it was accepted. If the item
did not receive a consensus vote, it was tabled for further discus-
sion at the end of the meeting. After the completion of voting on
each item, a discussion of the key elements that should be consid-
ered within the elaboration document occurred. Participants were
also asked to provide written suggestions for discussion points to
include in the elaboration document. Two non-voting assistants
served as record keepers to record the results of the voting, take
notes of the discussion, and collect additional written suggestions
on each item from the participants.
Preparation of Reporting Guidelines
After the meeting, the steering committee compiled a draft
report of the meeting that included the proposed modiﬁcations
to the STROBE statement, a summary of the suggestions for
the elaboration document, and a request for feedback from the
participants. The steering committee collated the comments, and
suggested revisions, and developed the modiﬁed STROBE state-
ment for observational studies in veterinary medicine related to
animal health, production, welfare, or food safety outcomes. A
draft of the STROBE-Vet statement was previewed by graduate
students (see details in the Results section). A draft of the elab-
oration document was then prepared by the steering committee
and circulated among the participants for input.
Results
In total, 23 experts were invited to participate in the
consensus meeting and 14 accepted, although one invitee
was subsequently unable to attend. The nine individuals
who declined had other commitments, including teaching
obligations during the time of the consensus meeting. All
four of the steering committee members attended for a
total of 17 participants. The methodological expertise of
the participants included epidemiology, statistics, system-
atic review and meta-analysis, and risk assessment, with
content expertise in food safety, health, production, and
welfare in food-producing, companion/recreation ani-
mals (e.g, dogs, cats, and horses), aquaculture, and
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wildlife. The group was comprised of seven individuals
working in Canada, ﬁve from the United States, four
from Europe, and one from Australia. There were 13 aca-
demicians, three emeritus academicians, and one govern-
ment employee. Members of the STROBE group were
consulted throughout the process, and two members
(Myriam Cevallos and Matthias Egger) participated in
the ﬁrst morning of the consensus meeting.
Nineteen pre-meeting surveys were completed by 12
of the 13 invitees, all four steering committee members,
and three additional individuals who were invited to the
consensus meeting, but were unable to attend. The indi-
vidual who accepted the invitation but was subsequently
unable to attend the meeting did not complete the pre-
meeting survey.
The participants agreed that the scope would include
observational studies with samples/information of ani-
mal origin with outcomes related to animal health, pro-
duction, welfare, or food safety. This wording was
meant to encompass a broad range of veterinary
research involving animals (including animal popula-
tions such as herds, farms, or ﬂocks), products of ani-
mal origin (such as meat or milk), or samples from
animals (such as blood or feces). Studies involving
human health outcomes related to animal exposure
were considered outside the scope of this initiative. For
these studies, the original STROBE statement would be
the appropriate guideline to use.
The participants agreed that the scope would include
both observational studies of hypotheses (hypothesis-
driven or hypothesis generating) and population-based
descriptive studies, such as those estimating the fre-
quency and distribution of disease. At least in the pre-
harvest food safety literature, it is common for disease
frequency estimates to be a key component of observa-
tional studies.4
The majority of items (whether modiﬁed or not)
received a consensus vote the ﬁrst time that a vote was
undertaken. Consensus was not achieved on the ﬁrst
vote for 2 items: item 4 and item 9. For item 4, the dis-
cussion revolved around whether the “key elements” of
study designs should be explicitly included in the item
itself. For item 9, the discussion pertained to whether
euthanasia represented a distinct source of bias (see fur-
ther discussion, below).
To meet the needs for a STROBE statement for
observational studies in veterinary research, the consen-
sus was that the following 16 items on the STROBE
checklist needed modiﬁcation to make them more
appropriate for veterinary medicine: 1 (title and
abstract), 3 (objectives), 5 (setting), 6 (participants), 7
(variables), 8 (data sources/measurement), 9 (bias), 10
(study size), 12 (statistical methods), 13 (participants),
14 (descriptive data), 15 (outcome data), 16 (main
results), 17 (other analyses), 19 (limitations), and 22
(funding) (Table 1). The participants identiﬁed the mod-
iﬁcation of these items as essential to the STROBE-Vet
statement checklist, rather than solely having these
issues discussed in the elaboration document.
Some of the modiﬁcations proposed to the STROBE
statement were minor wording changes intended to
provide more details for the veterinary community. For
example, item 1b (abstract) was modiﬁed to include
what the participants identiﬁed as key components of
an “informative and balanced summary” (the wording
used in the original STROBE statement).
Other modiﬁcations were more substantial. For
instance, throughout the STROBE statement, reference is
made to three common observational study designs (co-
hort, case-control, and cross-sectional), with the wording
of some reporting recommendations diﬀerent for the
three designs. However, in veterinary medicine, many
observational studies do not adhere strictly to one of
these three classical designs, and large population cohort
studies are rare. Therefore, the STROBE-Vet statement
does not make reference to the three common observa-
tional study designs, but rather focuses on reporting the
key features related to the observational research. This
modiﬁcation impacted items 1a, 6, 12, 14, and 15
(Table 1). An example of an addition is item 7 (vari-
ables), which now calls for the speciﬁcation of the puta-
tive causal structure (with a causal diagram being highly
encouraged) for all hypothesis-driven studies. Another
example is item 8 (data sources), which now calls for
information on questionnaire development (if relevant).
Also, throughout the STROBE statement the word “par-
ticipant” is used. In veterinary medicine, there generally
are two components to the concept of “participant:” the
owner/manager of the animals included in the study pop-
ulation and the animals themselves. Rather than modify-
ing the wording for participant throughout the checklist,
a footnote was added to note this point and to recom-
mend that relevant information concerning both types of
“participants” should be reported.
An issue that had relevance to several of the items
was that of non-independence of observations (items 3,
5, 6, 7, 10, 12a, 13a, 13b, 13c, 14a, 14b, and 15). It is
common in veterinary medicine, particularly in livestock
and shelter medicine (where companion animals are
kenneled), for animals to be housed or managed in
groups. Individuals within groups will tend to be more
similar to each other with respect to outcome status
compared with individuals in other groups, that is non-
independence of observational units. It is necessary to
account for any non-independence of the observational
units in the design, sampling strategy, and statistical
analysis to avoid violating the assumption of indepen-
dence underlying many statistical procedures. The
non-independence of observational units may be hierar-
chical, for instance animals within pens, pens within
barns, barns within same-owner facilities. However, this
is not always the case. For example, some organiza-
tional structures may not be purely hierarchical (e.g,
cross-classiﬁed data structures) and non-independence
can also result from repeated samples taken over time
from the same animal or facility.17 To be consistent
with the REFLECT statement12,13 www.reﬂect-
statement.org, “organizational structure” was used rather
than “hierarchy” throughout the STROBE-Vet state-
ment. In addition to modifying the wording of relevant
checklist items, the elaboration document includes dis-
cussion of this issue.
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Table 1. Modiﬁcations to the original STrengthening the Reporting of OBservational studies in Epidemiology
(STROBE) statement checklist for the STROBE-Vet statement.
Item STROBE Recommendation STROBE-Vet Recommendation
Title and Abstract 1 (a) Indicate the study’s design with a commonly
used term in the title or the abstract
(a) Indicate that the study was an observational
study and, if applicable, use a common study
design terma
(b) Provide in the abstract an informative and
balanced summary of what was done and
what was found
(b) Indicate why the study was conducted, the design,
the results, the limitations, and the relevance of the
ﬁndings
Introduction
Background/
Rationale
2 Explain the scientiﬁc background and
rationale for the investigation being reported
Explain the scientiﬁc background and rationale for
the investigation being reported
Objectives 3 State speciﬁc objectives, including any
prespeciﬁed hypotheses
(a) State speciﬁc objectives, including any primary or
secondary prespeciﬁed hypotheses or their absence
(b) Ensure that the level of organizationb is clear for
each objective and hypothesis
Methods
Study design 4 Present key elements of study design early
in the paper
Present key elements of study design early in the paper
Setting 5 Describe the setting, locations, and relevant
dates, including periods of recruitment,
exposure, follow-up, and data collection
(a) Describe the setting, locations, and relevant dates,
including periods of recruitment, exposure,
follow-up, and data collection
(b) If applicable, include information at each level
of organization
Participantsc 6 (a) Cohort study—Give the eligibility criteria,
and the sources and methods of selection of
participants. Describe methods of follow-up
Case-control study—Give the eligibility
criteria, and the sources and methods of
case ascertainment and control selection.
Give the rationale for the choice of cases
and controlsCross-sectional study—Give the
eligibility criteria, and the sources and
methods of selection of participants
(a) Describe the eligibility criteria for the owners/
managers and for the animals, at each relevant level
of organization
(b) Cohort study—For matched studies, give
matching criteria and number of exposed
and unexposed
Case-control study—For matched studies,
give matching criteria and the number of
controls per case
(b) Describe the sources and methods of selection for the
owners/managers and for the animals, at each
relevant level of organization
(c) Describe the method of follow-up
(d) For matched studies, describe matching criteria
and the number of matched individuals per subject
(e.g, number of controls per case)
Variables 7 Clearly deﬁne all outcomes, exposures,
predictors, potential confounders, and
eﬀect modiﬁers. Give diagnostic criteria,
if applicable
(a) Clearly deﬁne all outcomes, exposures, predictors,
potential confounders, and eﬀect modiﬁers. If
applicable, give diagnostic criteria
(b) Describe the level of organization at which each
variable was measured
(c) For hypothesis-driven studies, the putative causal
structure among variables should be described
(a diagram is strongly encouraged)
Data sources/
measurement
8d For each variable of interest, give sources
of data and details of methods of
assessment (measurement). Describe
comparability of assessment methods if
there is more than one group
(a) For each variable of interest, give sources of data
and details of methods of assessment (measurement).
If applicable, describe comparability of assessment
methods among groups and over time
(b) If a questionnaire was used to collect data,
describe its development, validation, and
administration
(c) Describe whether or not individuals involved in
data collection were blinded, when applicable
(continued)
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Table 1 (Continued)
Item STROBE Recommendation STROBE-Vet Recommendation
(d) Describe any eﬀorts to assess the accuracy of the
data (including methods used for “data cleaning” in
primary research, or methods used for validating
secondary data)
Bias 9 Describe any eﬀorts to address potential
sources of bias
Describe any eﬀorts to address potential sources of
bias due to confounding, selection, or information
bias
Study size 10 Describe how the study size was arrived at (a) Describe how the study size was arrived at for
each relevant level of organization
(b) Describe how non-independence of measurements
was incorporated into sample-size considerations,
if applicable
(c) If a formal sample-size calculation was used,
describe the parameters, assumptions, and methods
that were used, including a justiﬁcation for the
eﬀect size selected
Quantitative
variables
11 Explain how quantitative variables were
handled in the analyses. If applicable,
describe which groupings were chosen,
and why
Explain how quantitative variables were handled in
the analyses. If applicable, describe which groupings
were chosen, and why
Statistical
methods
12 (a) Describe all statistical methods,
including those used to control for
confounding
(a) Describe all statistical methods for each objective,
at a level of detail suﬃcient for a knowledgeable
reader to replicate the methods. Include a
description of the approaches to variable selection,
control of confounding, and methods used to
control for non-independence of observations
(b) Describe any methods used to examine
subgroups and interactions
(b) Describe the rationale for examining subgroups
and interactions and the methods used
(c) Explain how missing data were addressed (c) Explain how missing data were addressed
(d) Cohort study—If applicable, explain
how loss to follow-up was addressed
Case-control study—If applicable, explain
how matching of cases and controls was
addressed
Cross-sectional study—If applicable,
describe analytical methods taking
account of sampling strategy
(d) If applicable, describe the analytical approach to
loss to follow-up, matching, complex sampling, and
multiplicity of analyses
(e) Describe any sensitivity analyses (e) Describe any methods used to assess the
robustness of the analyses (e.g, sensitivity analyses
or quantitative bias assessment)
Results
Participants 13d (a) Report the numbers of individuals at
each stage of study—e.g, numbers
potentially eligible, examined for
eligibility, conﬁrmed eligible, included
in the study, completing follow-up, and
analyzed
(a) Report the numbers of owners/managers and
animals at each stage of study and at each relevant
level of organization - e.g, numbers eligible,
included in the study, completing follow-up,
and analyzed
(b) Give reasons for non-participation at
each stage
(b) Give reasons for non-participation at each stage
and at each relevant level of organization
(c) Consider use of a ﬂow diagram (c) Consider use of a ﬂow diagram, a diagram of the
organizational structure or both
Descriptive
data on
exposures and
potential
confounders
14d (a) Give characteristics of study
participants (e.g, demographic, clinical,
social) and information on exposures and
potential confounders
(a) Give characteristics of study participants
(e.g, demographic, clinical, social) and information
on exposures and potential confounders by group
and level of organization, if applicable
(b) Indicate number of participants with
missing data for each variable of interest
(b) Indicate number of participants with missing data
for each variable of interest and at all relevant
levels of organization
(c) Cohort study—Summarize follow-up
time (e.g, average and total amount)
(c) Summarize follow-up time (e.g, average and total
amount), if appropriate to the study design
(continued)
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The ﬁnal item in the STROBE checklist pertains to
funding sources. The STROBE-Vet statement substan-
tially expands this item to encompass the broader con-
cept of “transparency.” With numbered subitems, the
transparency item addresses sources of funding,
conﬂicts of interest, authors’ roles, ethical approval
(animal, human, or data use, as applicable), and the use
of any quality standards.
There was considerable discussion during the meet-
ing on the signiﬁcance of euthanasia in veterinary
Table 1 (Continued)
Item STROBE Recommendation STROBE-Vet Recommendation
Outcome data 15d Cohort study—Report numbers of outcome
events or summary measures over time
(a) Report outcomes as appropriate for the study
design and summarize at all relevant levels of
organization
Case-control study—Report numbers in
each exposure category, or summary
measures of exposure
(b) For proportions and rates, report the numerator
and denominator
Cross-sectional study—Report numbers of
outcome events or summary measures
(c) For continuous outcomes, report the number of
observations and a measure of variability
Main results 16 (a) Give unadjusted estimates and, if
applicable, confounder-adjusted estimates
and their precision (e.g, 95% conﬁdence
interval). Make clear which confounders
were adjusted for and why they were
included
(a) Give unadjusted estimates and, if applicable,
adjusted estimates and their precision (e.g, 95%
conﬁdence interval). Make clear which confounders
and interactions were adjusted. Report all relevant
parameters that were part of the model
(b) Report category boundaries when
continuous variables were categorized
(b) Report category boundaries when continuous
variables were categorized
(c) If relevant, consider translating estimates
of relative risk into absolute risk for a
meaningful time period
(c) If relevant, consider translating estimates of
relative risk into absolute risk for a meaningful
time period
Other analyses 17 Report other analyses done— analyses of
subgroups and interactions, and sensitivity analyses
Report other analyses done, such as sensitivity/
robustness analysis and analysis of subgroups
Discussion
Key results 18 Summarize key results with reference to
study objectives
Summarize key results with reference to study
objectives
Strengths and
Limitations
19 Discuss limitations of the study, taking
into account sources of potential bias or
imprecision. Discuss both direction and
magnitude of any potential bias
Discuss strengths and limitations of the study, taking
into account sources of potential bias or imprecision.
Discuss both direction and magnitude of any
potential bias
Interpretation 20 Give a cautious overall interpretation of
results considering objectives, limitations,
multiplicity of analyses, results from
similar studies, and other relevant evidence
Give a cautious overall interpretation of results
considering objectives, limitations, multiplicity of
analyses, results from similar studies, and other
relevant evidence
Generalizability 21 Discuss the generalizability (external
validity) of the study results
Discuss the generalizability (external validity) of the
study results
Other Information
Transparency 22 Give the source of funding and the role of
the funders for the present study and, if
applicable, for the original study on
which the present article is based
(a) Funding—Give the source of funding and the role
of the funders for the present study and, if
applicable, for the original study on which the
present article is based(b) Conﬂicts of interest—
Describe any conﬂicts of interest, or lack thereof,
for each author(c) Describe the authors’ roles—
Provision of an authors’ declaration of transparency
is recommended(d) Ethical approval—Include
information on ethical approval for use of animal
and human subjects(e) Quality standards—Describe
any quality standards used in the conduct of the
research
aUnderlined text represents modiﬁcations or additions to the original STROBE wording.
bLevel of organization recognizes that observational studies in veterinary research often deal with repeated measures (within an animal
or herd) or animals that are maintained in groups (such as pens and herds); thus, the observations are not statistically independent. This
non-independence has profound implications for the design, analysis, and results of these studies.
cThe word “participant” is used in the STROBE statement. However, for the veterinary version, it is understood that “participant”
should be addressed for both the animal owner/manager and for the animals themselves.
dGive such information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in
cohort and cross-sectional studies.
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medicine. It is possible, and common under some dis-
ease or production circumstances, for animals to be
euthanized or electively culled during studies. There is
no equivalent to this in human medicine; therefore,
much discussion was devoted to this topic. Although
the participants agreed that the occurrence and fre-
quency of euthanasia or culling should be reported in
studies where it occurred, there were diﬀering opin-
ions as to whether euthanasia is a distinct issue
related to the potential for information or selection
bias, or whether it is just a component of a death/
survival outcome that needs to be reported. At the
end of the meeting, a vote was held and the consen-
sus was to include a discussion of euthanasia in the
elaboration document, but not to modify the wording
within the STROBE-Vet expansion.
The draft statement was previewed by 17 graduate
students from two graduate student journal clubs (Epi-
demiology Journal Club and Ruminant Group Journal
Club) in the Department of Population Medicine at the
University of Guelph. The students identiﬁed phrases
for which they would like clariﬁcation or further expla-
nation. Their comments were incorporated into the
elaboration document.
Discussion
Here, the development of an extension to the
STROBE statement for reporting observational studies
in veterinary research is described. The intention of these
guidelines, in concordance with the STROBE statement,
is to provide guidance for authors when describing the
design and results of observational studies. The guideli-
nes are also useful for editors, peer reviewers, and read-
ers of observational study reports. It is intended that
these guidelines will be applicable to the broad range of
research questions addressed in veterinary medicine with
observational studies, including studies in which the
objective was to describe disease occurrence, exploratory
studies used to generate hypotheses, and hypothesis-dri-
ven studies. The guidelines are applicable to research
conducted in both developed and developing nations. It
is not the intention for these guidelines to be prescriptive
regarding format or order of reporting based on the item
numbering. The items in the STROBE-Vet expansion
were ordered to correspond to the items in the STROBE
statement, which follows the typical order of sections
within a scientiﬁc manuscript. It is important that all of
the relevant checklist items are addressed in suﬃcient
detail within a manuscript.
The STROBE-Vet guidelines are also not intended to
be prescriptive about the conduct of observational stud-
ies, but rather they focus on the clarity of reporting simi-
lar to that of the STROBE statement.18 Likewise, the
STROBE-Vet statement is also not intended to be used
as a tool to assess the quality of the research design or
execution.5 Both the issue of prescriptive design and use
for quality assessment have been identiﬁed in the litera-
ture as misuses of the STROBE statement.19 There are
several systematic reviews published on quality assess-
ment tools for observational research.20–22
The guidelines presented herein represent the consen-
sus of a group of individuals deemed to be experts in
observational studies in veterinary research, and thus,
the results represent expert opinion. A systematic review
of published literature was not conducted for any of the
items, and published evidence was not always available
to support modiﬁcation to or inclusion of an item. The
steering committee attempted to balance content exper-
tise and, to some extent, geographic location of the
selected participants. However, the existing networks of
the steering committee members inﬂuenced participant
selection, the necessity for the experts to self-fund their
travel resulted in a predominance of North American
experts, and the steering committee members knew each
other professionally prior to this initiative. Therefore,
there is the potential for selection bias to have impacted
our results. We expect that these guidelines will evolve
over time and we welcome comments or suggestions.
When used in conjunction with the Explanation and
Elaboration document, we expect that these guidelines
will lead to improved reporting of observational
research in veterinary medicine.
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